Stepwise differentiation of airway epithelial cells from human tonsil-derived mesenchymal stem cells.

IF 7.1 2区 医学 Q1 CELL & TISSUE ENGINEERING
Ha Yeong Kim, Jiin Yang, Han Su Kim, Soo Yeon Jung
{"title":"Stepwise differentiation of airway epithelial cells from human tonsil-derived mesenchymal stem cells.","authors":"Ha Yeong Kim, Jiin Yang, Han Su Kim, Soo Yeon Jung","doi":"10.1186/s13287-025-04397-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Airway defects, often resulting from tumor resection, trauma, or infection, pose significant treatment challenges owing to the intricate, multilayered structure of the airway. Successful recovery depends on reconstructing the respiratory epithelium, the lining next to the cartilage. Although autologous epithelial or progenitor cells are used to reconstruct the epithelium, they are not ideal for regeneration because of difficulties in expansion and differentiation in vitro. In this study, we developed an alternative approach to respiratory epithelial regeneration using human tonsil-derived mesenchymal stem cells (TMSCs) to induce epithelial cell differentiation through a stepwise process.</p><p><strong>Methods: </strong>TMSCs were isolated from the human tonsillar tissues of patients undergoing tonsillectomy and differentiated into airway epithelial cells following human embryonic development. To generate airway epithelial cells, TMSCs were exposed to various chemical agents or protein combinations during a 4-step process.</p><p><strong>Results: </strong>We observed that TMSCs can be induced into the definitive endoderm (DE) with a low concentration of activin A, activating the Nodal/TGF-β signaling pathway. Subsequently, a combination of growth factors regulating BMP, TGF-β, and Wnt signaling induces the differentiation of TMSC-derived DE cells into anterior foregut endoderm, identified by upregulating PAX9, SOX2, and GATA3 gene expression. In the final 3-4 steps, an environment rich in Wnt and FGFs differentiated TMSCs into airway epithelial cells through lung progenitor cells, as evidenced by the increased gene expression of lung progenitor cell markers (NKX2-1), airway cell markers (KRT5), and ciliated cell markers (FoxJ1). Specifically, TMSC-derived airway epithelial cells exhibited a columnar epithelial structure resembling an F-actin filament structure.</p><p><strong>Conclusions: </strong>Our results demonstrated that TMSC-derived airway epithelial cells can be generated through stepwise differentiation and represent a potential alternative for the functional recovery of respiratory defects.</p>","PeriodicalId":21876,"journal":{"name":"Stem Cell Research & Therapy","volume":"16 1","pages":"354"},"PeriodicalIF":7.1000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12235983/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem Cell Research & Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13287-025-04397-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Airway defects, often resulting from tumor resection, trauma, or infection, pose significant treatment challenges owing to the intricate, multilayered structure of the airway. Successful recovery depends on reconstructing the respiratory epithelium, the lining next to the cartilage. Although autologous epithelial or progenitor cells are used to reconstruct the epithelium, they are not ideal for regeneration because of difficulties in expansion and differentiation in vitro. In this study, we developed an alternative approach to respiratory epithelial regeneration using human tonsil-derived mesenchymal stem cells (TMSCs) to induce epithelial cell differentiation through a stepwise process.

Methods: TMSCs were isolated from the human tonsillar tissues of patients undergoing tonsillectomy and differentiated into airway epithelial cells following human embryonic development. To generate airway epithelial cells, TMSCs were exposed to various chemical agents or protein combinations during a 4-step process.

Results: We observed that TMSCs can be induced into the definitive endoderm (DE) with a low concentration of activin A, activating the Nodal/TGF-β signaling pathway. Subsequently, a combination of growth factors regulating BMP, TGF-β, and Wnt signaling induces the differentiation of TMSC-derived DE cells into anterior foregut endoderm, identified by upregulating PAX9, SOX2, and GATA3 gene expression. In the final 3-4 steps, an environment rich in Wnt and FGFs differentiated TMSCs into airway epithelial cells through lung progenitor cells, as evidenced by the increased gene expression of lung progenitor cell markers (NKX2-1), airway cell markers (KRT5), and ciliated cell markers (FoxJ1). Specifically, TMSC-derived airway epithelial cells exhibited a columnar epithelial structure resembling an F-actin filament structure.

Conclusions: Our results demonstrated that TMSC-derived airway epithelial cells can be generated through stepwise differentiation and represent a potential alternative for the functional recovery of respiratory defects.

气道上皮细胞与人扁桃体源性间充质干细胞的逐步分化。
背景:气道缺损通常由肿瘤切除、创伤或感染引起,由于气道复杂的多层结构,给治疗带来了重大挑战。成功的恢复依赖于重建呼吸上皮,即靠近软骨的内膜。虽然使用自体上皮细胞或祖细胞重建上皮,但由于体外扩增和分化困难,它们不是理想的再生细胞。在这项研究中,我们开发了一种替代的呼吸上皮再生方法,使用人扁桃体来源的间充质干细胞(TMSCs)通过逐步的过程诱导上皮细胞分化。方法:从扁桃体切除术患者的扁桃体组织中分离TMSCs,并在人胚胎发育后分化为气道上皮细胞。为了生成气道上皮细胞,在4步过程中,将TMSCs暴露于各种化学剂或蛋白质组合中。结果:我们观察到低浓度的激活素a可以诱导TMSCs进入最终内胚层(DE),激活Nodal/TGF-β信号通路。随后,一系列调节BMP、TGF-β和Wnt信号的生长因子通过上调PAX9、SOX2和GATA3基因表达,诱导tmsc来源的DE细胞向前肠内胚层分化。在最后的3-4个步骤中,富含Wnt和FGFs的环境通过肺祖细胞将TMSCs分化为气道上皮细胞,肺祖细胞标记物(NKX2-1)、气道细胞标记物(KRT5)和纤毛细胞标记物(FoxJ1)的基因表达增加。具体来说,tmsc衍生的气道上皮细胞表现出类似于f -肌动蛋白丝结构的柱状上皮结构。结论:我们的研究结果表明,tmsc衍生的气道上皮细胞可以通过逐步分化产生,并代表了呼吸缺陷功能恢复的潜在替代方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Stem Cell Research & Therapy
Stem Cell Research & Therapy CELL BIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
CiteScore
13.20
自引率
8.00%
发文量
525
审稿时长
1 months
期刊介绍: Stem Cell Research & Therapy serves as a leading platform for translational research in stem cell therapies. This international, peer-reviewed journal publishes high-quality open-access research articles, with a focus on basic, translational, and clinical research in stem cell therapeutics and regenerative therapies. Coverage includes animal models and clinical trials. Additionally, the journal offers reviews, viewpoints, commentaries, and reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信